[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fqEd5zpAvxVSVA2HHhuXvcJ00AGQawQLAM-vPnDJNmOQ":8,"$f0JjCstdef9UP1VjWNSASi2gCNnVbUeVgkacRvctPxaY":55,"$ff-biHYhRskmjue5rfYwoFgO06Hw5lU5Nyu85okaF7ZU":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},58902,867451,[],"https://ystcdn.venuertc.com/medical/ystApp/t0US13DNdGYbbVXINAX1q5n2vRwR8fnc.png","霍文捷","山西省人民医院","肿瘤科","主治医师",109,0,"浸润性导管癌Luminal B型常用药品：用药细节与安全指南","","https://ystcdn.venuertc.com/venue/AI/1c191357-8380-42ae-852b-e5bbff763c43.jpg","\u003Cdiv class=\"custom-mammarydrug-root\">\n  \u003Ch2 id=\"material_title\" class=\"custom-mammarydrug-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">浸润性导管癌Luminal B型常用药品：用药细节与安全指南\u003C/h2>\n  \n  \u003Cdiv class=\"custom-mammarydrug-section custom-mammarydrug-bg1\">\n    \u003Ch2 class=\"custom-mammarydrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01. 导言——认识乳腺肿瘤治疗药物\u003C/h2>\n    \u003Cp class=\"custom-mammarydrug-p\">\n      说起来，治疗乳腺相关疾病时，常见的药物涉及化疗、内分泌调节、针对副作用的支持治疗等多个类别。例如紫杉醇类、粒细胞刺激因子、抗激素药物与支持药物都有各自独特的机制和应用。能否正确掌握使用细节，直接影响到疗效和安全。今天将结合临床实际，把治疗过程中常用的主要药品安全用药细节分成八条，帮您快速掌握，安心用药。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 药理作用与分类 -->\n  \u003Cdiv class=\"custom-mammarydrug-section custom-mammarydrug-bg2\">\n    \u003Ch2 class=\"custom-mammarydrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02. 药物类别及作用机制 ⚗️\u003C/h2>\n    \u003Cul class=\"custom-mammarydrug-list\">\n      \u003Cli>\n        \u003Cstrong>白蛋白结合型紫杉醇\u003C/strong>：属于紫杉醇类抗肿瘤药。通过扰乱微管动态，抑制细胞分裂生长，阻止肿瘤细胞增殖。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>粒细胞刺激因子\u003C/strong>：属于重组蛋白药。促进骨髓产生中性粒细胞，降低感染风险，常用于化疗期间白细胞下降时。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>抗激素/内分泌治疗药物\u003C/strong>：如他莫昔芬、芳香化酶抑制剂等，主要通过抑制雌激素活性，间接减缓相关细胞的分裂增长。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>止吐、护胃、护肝药物\u003C/strong>：分别对应化疗副反应的抑制（如5-HT\u003Csub>3\u003C/sub>受体拮抗剂）、胃黏膜保护（如质子泵抑制剂）、肝功能辅助（如多烯磷脂酰胆碱等），保证整体耐受。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"custom-mammarydrug-tip\">📘 参考文献：Jordan, V.C. (2003). Tamoxifen: a most unlikely pioneering medicine. Natural Reviews Drug Discovery, 2(3), 205-213. https://doi.org/10.1038/nrd1033\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 剂型特点与服用技巧 -->\n  \u003Cdiv class=\"custom-mammarydrug-section custom-mammarydrug-bg3\">\n    \u003Ch2 class=\"custom-mammarydrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03. 剂型区分与使用方法 🚰\u003C/h2>\n    \u003Cp class=\"custom-mammarydrug-p\">\n      不同剂型的药品用法细节有所差异，直接关系吸收与效果：\n    \u003C/p>\n    \u003Cul class=\"custom-mammarydrug-list\">\n      \u003Cli>\n        \u003Cstrong>白蛋白结合型紫杉醇\u003C/strong>：需静脉滴注，并严格按照标准时间进行（通常30分钟～1小时），不能推注。输注过程中需密切观察。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>粒细胞刺激因子\u003C/strong>：以皮下注射为主。注射部位轮换，避免长期固定位置带来皮肤硬结。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>抗激素药物\u003C/strong>：如口服片剂，他莫昔芬或芳香化酶抑制剂，多建议每日固定时间整片服用，优选餐后，温水送服。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>止吐药、护肝/护胃药\u003C/strong>：如为口服片剂，要用足量饮水吞服，不可嚼碎（肠溶片等更需注意）。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"custom-mammarydrug-tip\">📝 正确做法：遵照说明书要求的服用方式，切忌自行变更剂型、服用方法。\u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 用药时间与规律 -->\n  \u003Cdiv class=\"custom-mammarydrug-section custom-mammarydrug-bg4\">\n    \u003Ch2 class=\"custom-mammarydrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04. 服药时间及规律重要性 ⏰\u003C/h2>\n    \u003Cul class=\"custom-mammarydrug-list\">\n      \u003Cli>\n        \u003Cstrong>化疗药物\u003C/strong>：标准方案按照周期给予，比如每周或每三周一次，治疗期间切勿随意延误或提前，周期更改须咨询医生。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>内分泌/抗激素药\u003C/strong>：必须每日服用，保持血药浓度稳定，同一时间服药能减少漏服风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>粒细胞刺激因子\u003C/strong>：通常在化疗后1～3天应用，疗程及频率视白细胞恢复进度调整。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>辅助止吐、护肝药\u003C/strong>：按说明书定时用药，不可随意中断。化疗前半小时服用止吐药能够预防反应。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"custom-mammarydrug-tip\">\n      案例分享：在临床中，一位58岁的女性患者按化疗药物周期静脉用药，搭配辅助药物规律使用，疗效与耐受性显著提升。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 药物相互作用 -->\n  \u003Cdiv class=\"custom-mammarydrug-section custom-mammarydrug-bg5\">\n    \u003Ch2 class=\"custom-mammarydrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05. 药物相互作用及需避开的联合药 🍵\u003C/h2>\n    \u003Cul class=\"custom-mammarydrug-list\">\n      \u003Cli>\n        \u003Cstrong>紫杉醇类\u003C/strong>：与酮康唑、红霉素等强CYP3A4抑制剂合用时，可能影响药物代谢，造成毒性增加。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>抗激素类药\u003C/strong>：如他莫昔芬不得与部分抗抑郁药（如帕罗西汀、氟西汀）合用，否则药效下降。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>质子泵抑制剂（护胃药）\u003C/strong>：与部分抗肿瘤口服药联用，可能影响吸收。使用时请询问医师是否需要间隔服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>辅助药品\u003C/strong>：如护肝药与化疗药需间隔至少1小时，避免互相干扰代谢。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"custom-mammarydrug-tip\">\n      参考文献：Goetz, M.P., Toi, M., Campone, M., et al. (2017). MONARCH 3: Abemaciclib as Initial Therapy for Advanced Breast Cancer. JCO, 35(32), 3638–3646. https://doi.org/10.1200/JCO.2017.75.6155\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 适应症与禁忌症分开讲 -->\n  \u003Cdiv class=\"custom-mammarydrug-section custom-mammarydrug-bg6\">\n    \u003Ch2 class=\"custom-mammarydrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06. 适应症与用药禁忌 🚫\u003C/h2>\n    \u003Cul class=\"custom-mammarydrug-list\">\n      \u003Cli>\n        \u003Cstrong>适应症\u003C/strong>：\n        \u003Cul class=\"custom-mammarydrug-sublist\">\n          \u003Cli>白蛋白结合型紫杉醇：用于乳腺相关肿瘤的化疗阶段。\u003C/li>\n          \u003Cli>粒细胞刺激因子：用于刺激白细胞生成，预防化疗相关性粒细胞减少。\u003C/li>\n          \u003Cli>抗激素药物：适用于激素敏感型乳腺疾病的辅助或长期治疗。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>禁忌症\u003C/strong>：\n        \u003Cul class=\"custom-mammarydrug-sublist\">\n          \u003Cli>对紫杉醇或其制剂成分过敏者禁用。\u003C/li>\n          \u003Cli>严重肝功能损害患者不可用大部分紫杉醇类药。\u003C/li>\n          \u003Cli>粒细胞刺激因子禁用于部分白血病及骨髓增生异常综合征患者。\u003C/li>\n          \u003Cli>严重过敏反应、药物不耐受及特殊代谢障碍患者应慎用所有上述药物。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"custom-mammarydrug-tip\">\n      特别提醒：所有用药禁忌必须遵照药品说明书和医生建议执行，不得擅自用药或停药。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 不良反应及处理 -->\n  \u003Cdiv class=\"custom-mammarydrug-section custom-mammarydrug-bg7\">\n    \u003Ch2 class=\"custom-mammarydrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07. 常见不良反应及处理方式 ⚠️\u003C/h2>\n    \u003Cul class=\"custom-mammarydrug-list\">\n      \u003Cli>\n        \u003Cstrong>紫杉醇类药物\u003C/strong>：易出现脱发、白细胞减少、周围神经麻木等，部分患者有轻度过敏反应。\n        \u003Cdiv class=\"custom-mammarydrug-hint\">正确做法：用药期间密切监测血常规，若白细胞显著下降遵医嘱调整方案。出现麻木可请医生评估调整给药速度/剂量。\u003C/div>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>粒细胞刺激因子\u003C/strong>：部分人有肌肉、骨骼酸痛，极少数可能出现过敏反应。\n        \u003Cdiv class=\"custom-mammarydrug-hint\">正确做法：酸痛多可缓解，若反应剧烈或出现呼吸困难，须立即停药并就医。\u003C/div>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>抗激素药物\u003C/strong>：最常见为潮热、关节不适，部分患者发生血栓风险略增。\n        \u003Cdiv class=\"custom-mammarydrug-hint\">正确做法：症状轻微可耐受，明显不适时及时联系医生咨询调整策略。\u003C/div>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>辅助护肝、护胃药\u003C/strong>：多数耐受好，偶有轻度肠胃不适、皮疹。\n        \u003Cdiv class=\"custom-mammarydrug-hint\">正确做法：持续不适需暂停用药并及时评估是否更换药品。\u003C/div>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"custom-mammarydrug-tip\">\n      临床数据显示，紫杉醇类白细胞减少、脱发的发生率均高于30%，不良反应需全程关注。（来源：Pivot, X., et al. (2008). JCO, 26(8), 1372-1379. https://doi.org/10.1200/JCO.2007.12.7557）\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 特殊人群及用药调整 -->\n  \u003Cdiv class=\"custom-mammarydrug-section custom-mammarydrug-bg8\">\n    \u003Ch2 class=\"custom-mammarydrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08. 特殊人群用药须知 👩‍🦳👨‍👩‍👧‍👦\u003C/h2>\n    \u003Cul class=\"custom-mammarydrug-list\">\n      \u003Cli>\n        \u003Cstrong>老年患者\u003C/strong>：肝肾功能减退，建议个体化调整化疗及辅助药剂量，密切监测肝肾功能。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>孕妇、备孕及哺乳期女性\u003C/strong>：大部分化疗及内分泌药品严格禁用；有用药需求务必先与专业医师沟通。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>肝肾功能不全\u003C/strong>：紫杉醇、部分辅助药须调减剂量或替换，具体遵专业医嘱。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>青少年及儿童\u003C/strong>：不推荐上述主要药物常规使用，极特殊情况下方可个体化调整。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"custom-mammarydrug-tip\">\n      案例参考：临床上老年女性患者调整化疗和内分泌剂量，可显著降低不良反应风险，提高耐受性。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 储存及有效期管理 -->\n  \u003Cdiv class=\"custom-mammarydrug-section custom-mammarydrug-bg9\">\n    \u003Ch2 class=\"custom-mammarydrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09. 储存环境、开封与过期管理 📦\u003C/h2>\n    \u003Cul class=\"custom-mammarydrug-list\">\n      \u003Cli>\n        \u003Cstrong>静脉输注制剂（如紫杉醇、粒细胞刺激因子）\u003C/strong>：未开封应存放在2-8℃冰箱，避免冷冻。配制后用药应在规定时间内用完，并避免阳光直射。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>口服片剂/胶囊/滴丸\u003C/strong>：存于阴凉干燥处，防潮。开瓶后注意防止回潮，定期检查药品外观及气味变化。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>开封后\u003C/strong>：多数药品建议1个月内用完，超过有效期或外观异常不再继续服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>过期药品处理\u003C/strong>：按说明书或药师指导规范丢弃，严禁混入生活垃圾或倒入下水道，以防环境污染。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"custom-mammarydrug-tip\">\n      储存失当会导致药品活性降低或产生危害，常温暴晒或湿热环境下禁用高风险药品。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 漏服与过量处理 -->\n  \u003Cdiv class=\"custom-mammarydrug-section custom-mammarydrug-bg10\">\n    \u003Ch2 class=\"custom-mammarydrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10. 漏服与过量应对 🕳️\u003C/h2>\n    \u003Cul class=\"custom-mammarydrug-list\">\n      \u003Cli>\n        \u003Cstrong>内分泌药物等片剂\u003C/strong>：漏服应尽快补服；若接近下一次用药时间，可跳过，不可一次服用双倍剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>化疗药/注射制剂\u003C/strong>：漏用或过量均不可自行处理。正确做法：立即联系医师或药师，由专业人员指导补救方案。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>辅助药品（护胃、止吐、护肝）\u003C/strong>：忘服多为一次影响较小，补服方案同上，但连续多次漏服需重新评估副作用控制。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"custom-mammarydrug-tip\">\n      非常关键：过量服用疑有中毒症状时，需第一时间就医，不可依赖家庭常规方法自主处理。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 总结与建议 -->\n  \u003Cdiv class=\"custom-mammarydrug-section custom-mammarydrug-bg11\">\n    \u003Ch2 class=\"custom-mammarydrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11. 总结与安全用药提醒 📝\u003C/h2>\n    \u003Cp class=\"custom-mammarydrug-p\">\n      对于化疗、内分泌治疗及抗副作用类药物，\u003Cb>服用方法的细节\u003C/b>决定疗效与安全。每一种药品在时间、剂型、相互作用、特殊人群适应上都需严格区分。尤其化疗期间的静脉制剂和抗激素药，剂量调整、用药周期及防护措施一个都不能少。牢记漏服及时补救、特殊症状立刻就医，并把握正确的储存和过期处理方式。合理用药才能最大程度获得治疗收益、减少风险。如对药物有疑问，应及时与医生或药师交流，不要自行作出用药决定。\n    \u003C/p>\n    \u003Cdiv class=\"custom-mammarydrug-tip\">\n      安全用药，从细节开始。所有信息仅供用药参考，具体方案以医生指导为准。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"custom-mammarydrug-section\">\n    \u003Ch3 class=\"custom-mammarydrug-ref-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔖 主要参考文献\u003C/h3>\n    \u003Cul class=\"custom-mammarydrug-ref-list\">\n      \u003Cli>\n        Jordan, V.C. (2003). Tamoxifen: a most unlikely pioneering medicine. \u003Ci>Nature Reviews Drug Discovery, 2\u003C/i>(3), 205-213. https://doi.org/10.1038/nrd1033\n      \u003C/li>\n      \u003Cli>\n        Goetz, M.P., Toi, M., Campone, M., et al. (2017). MONARCH 3: Abemaciclib as Initial Therapy for Advanced Breast Cancer. \u003Ci>Journal of Clinical Oncology, 35\u003C/i>(32), 3638–3646. https://doi.org/10.1200/JCO.2017.75.6155\n      \u003C/li>\n      \u003Cli>\n        Pivot, X., et al. (2008). Activity of docetaxel in advanced breast cancer: A review. \u003Ci>Journal of Clinical Oncology, 26\u003C/i>(8), 1372-1379. https://doi.org/10.1200/JCO.2007.12.7557\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.custom-mammarydrug-root {\n  font-family: \"Helvetica Neue\", Helvetica, Arial, \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei\", sans-serif;\n  color: #2d373c;\n  background: #f8fafc;\n  max-width: 820px;\n  margin: 0 auto;\n  padding: 22px 16px 46px 16px;\n  border-radius: 14px;\n  box-shadow: 0 4px 32px rgba(53,94,130, 0.07);\n}\n.custom-mammarydrug-title {\n  font-size: 2.25em;\n  color: #243648;\n  font-weight: bold;\n  margin-bottom: 18px;\n  letter-spacing: 0.02em;\n  text-align: left;\n}\n.custom-mammarydrug-section {\n  margin-bottom: 32px;\n  padding: 22px 22px 22px 22px;\n  border-radius: 10px;\n  background: #fff;\n  box-shadow: 0 2px 10px rgba(206,221,243,0.10);\n}\n.custom-mammarydrug-bg1 { background: linear-gradient(102deg, #f5f8ff 70%, #e3ecfb 100%); }\n.custom-mammarydrug-bg2 { background: linear-gradient(95deg,#f7fcf6 60%, #e7f6e8 100%); }\n.custom-mammarydrug-bg3 { background: linear-gradient(97deg, #fff9f3 60%, #f7ebe0 100%);}\n.custom-mammarydrug-bg4 { background: linear-gradient(103deg,#f3fbff 72%, #e2f4fa 100%);}\n.custom-mammarydrug-bg5 { background: linear-gradient(100deg, #faf7ff 60%, #e9e6fd 100%);}\n.custom-mammarydrug-bg6 { background: linear-gradient(90deg, #fffaf7 70%, #ffe9d7 100%);}\n.custom-mammarydrug-bg7 { background: linear-gradient(98deg,#fff7fb 67%, #fadbe8 100%);}\n.custom-mammarydrug-bg8 { background: linear-gradient(92deg,#f6fbfa 60%, #ddf6f1 100%);}\n.custom-mammarydrug-bg9 { background: linear-gradient(100deg,#f9faf5 80%, #eaeedc 100%);}\n.custom-mammarydrug-bg10 { background: linear-gradient(94deg,#f7f9ff 60%, #e5e8fd 100%);}\n.custom-mammarydrug-bg11 { background: linear-gradient(96deg,#f5fbf6 72%, #d6f4e2 100%);}\n\n.custom-mammarydrug-subtitle {\n  font-size: 1.38em;\n  font-weight: 600;\n  margin-bottom: 12px;\n  color: #20406a;\n  letter-spacing: 0.02em;\n  background: rgba(135,183,253,0.07);\n  padding: 7px 14px 7px 14px;\n  border-radius: 9px;\n  display: inline-block;\n  margin-top: 0;\n}\n\n.custom-mammarydrug-p {\n  font-size: 1.08em;\n  line-height: 1.85em;\n  margin: 8px 0 0 0;\n  color: #23313a;\n  text-align: left;\n}\n\n.custom-mammarydrug-list {\n  margin-top: 9px;\n  margin-bottom: 8px;\n  padding-left: 24px;\n  font-size: 1.03em;\n}\n.custom-mammarydrug-list > li {\n  margin-bottom: 10px;\n  line-height:1.7em;\n}\n.custom-mammarydrug-sublist {\n  margin-left: 22px;\n  margin-top: 7px;\n  margin-bottom: 6px;\n  color: #3a4a56;\n}\n.custom-mammarydrug-tip {\n  background: #eaf3fa;\n  border-left: 5px solid #4598e6;\n  color: #37629c;\n  font-size: 1em;\n  padding: 9px 13px;\n  border-radius: 8px;\n  margin-top: 18px;\n  margin-bottom: 0;\n  line-height: 1.7em;\n}\n.custom-mammarydrug-hint {\n  background: #faf6e4;\n  border-left: 4px solid #f7c67f;\n  color: #908040;\n  font-size: 0.98em;\n  padding: 5px 10px;\n  border-radius: 7px;\n  display:inline-block;\n  margin-top: 7px;\n}\n.custom-mammarydrug-ref-title {\n  font-size: 1.12em;\n  font-weight: bold;\n  color: #20406a;\n  margin-bottom: 9px;\n  margin-top: 6px;\n}\n.custom-mammarydrug-ref-list {\n  font-size:0.94em;\n  color:#456488;\n  padding-left:24px;\n  margin-top:0;\n}\n.custom-mammarydrug-ref-list li{\n  margin-bottom:5px;\n  word-break: break-all;\n}\n@media (max-width: 540px) {\n  .custom-mammarydrug-root { padding: 7px 2px 18px 2px;}\n  .custom-mammarydrug-title { font-size: 1.38em; }\n  .custom-mammarydrug-section { padding:10px 6px;}\n  .custom-mammarydrug-ref-list {padding-left:14px;}\n}\n\n\u003C/style>\n","\u003Cdiv class=\"custom-mammarydrug-root\">\n  \u003Ch2 id=\"material_title\" class=\"custom-mammarydrug-title\" sty",514,"2025-08-14 10:36:34","浸润性导管癌, Luminal B型, 化疗药物, 内分泌治疗, 用药安全指南, 疗效管理, 不良反应, 药物相互作用","全面了解浸润性导管癌Luminal B型常用药品的用药细节与安全指南，掌握化疗与内分泌药物的疗效与安全关键，确保有效治疗与副作用管理。","2025-08-15 19:12:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]